Wounded Warrior Project Partners with Cohen Veterans Bioscience to Treat PTSD

Post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) are considered the signature wounds of the wars in Afghanistan and Iraq. It is estimated that 500,000 veterans live with the symptoms of PTSD; around 320,000 have a TBI.

These trauma-related issues can contribute significantly to suicidal thoughts or tendencies. It is estimated more than 20 veterans take their life each day. There are few proven methods to accurately diagnose and treat PTSD and TBI.

Today, Wounded Warrior Project (WWP) and Cohen Veterans Bioscience (CVB) announced a shared initiative to better diagnose and treat PTSD and TBI. The collaboration, known as Research Alliance for PTSD/TBI Innovation and Discovery Diagnostics (RAPID-Dx), is a public-private partnership led by CVB with WWP supporting biomarker research.

Biomarkers help doctors measure the effectiveness of treatment better than what a patient reports on his or her own health. RAPID-Dx helps discover, replicate, and qualify biomarkers for PTSD and TBI care.

“Identifying biomarkers is an important step in care for PTSD and TBI,” said Mike Richardson, WWP vice president of mental health and independence services. “We can better target treatment to individual patients and see improved results.”

The partnership between RAPID-Dx and Warrior Care Network will help expand this important research. Warrior Care Network is an innovative partnership between WWP, four top academic medical centers, and the Department of Veterans Affairs (VA). Warrior Care Network treats the invisible wounds of war through intensive outpatient programs.

“RAPID-Dx will provide vital information for the precision treatment of patients with PTSD and TBI,” said Dr. Magali Haas, CEO of Cohen Veterans Bioscience. “This partnership represents a best-in-class approach to helping the thousands of veterans in need, as well as others affected by these debilitating injuries.”

About the Wounded Warrior Project (WWP)

Wounded Warrior Project (WWP) began in 2003 as a small, grassroots effort providing simple care and comfort items to the hospital bedsides of the first wounded service members returning home from the conflicts in Iraq and Afghanistan. As their post-service needs evolved, so have our programs and services. Today, through our direct programs in mental health, career counseling, and long-term rehabilitative care, along with our advocacy efforts, we improve the lives of millions of warriors and their families.

Share this article:

More from CVB

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

A Message from CEO Peter Hoehn

https://www.cohenveteransbioscience.org/wp-content/themes/cvb-theme/assets/img/icon-news-card.png

CVB President Nicole Harmon, PhD Discusses How Traumatic Brain Injury Has Impacted Her Family

https://www.cohenveteransbioscience.org/wp-content/uploads/2024/01/bibi-C-3.jpg

Interview with Bibi Carmouche, BASE Jumper for 22 Jumps Camelback Mountain 2024

https://www.cohenveteransbioscience.org/wp-content/uploads/2023/03/cohen-veterans-bioscience-22-jumps.jpg

Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Crisis of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.

For Media Inquiries

Please feel free to email us at media@cohenbio.org